drugset / Trial / NCT03406676

Pre-treatment With Methylene Blue Prevent Peri-operative Reduced Systemic Vascular Resistance

NCT03406676

Unknown 70 enrolled Southwest Hospital, China
RandomizedParallel-groupDouble-blindPrevention

Summary

To explore the effects of pre-treatment with methylene blue on reduced perioperative vascular resistance in patients with obstructive jaundice.

Timeline

Start
2017-08-01
Primary completion
2018-10-30
Completion
2018-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylene Blue Diagnostic / imaging agent 2 mg/kg Intravenous

Indications